Literature DB >> 31851289

SAMMI: a semi-automated tool for the visualization of metabolic networks.

Andre Schultz1, Rehan Akbani1.   

Abstract

SUMMARY: Here we present a browser-based Semi-Automated Metabolic Map Illustrator (SAMMI) for the visualization of metabolic networks. While automated features allow for easy network partitioning, navigation, and node positioning, SAMMI also offers a wide array of manual map editing features. This combination allows for fast, context-specific visualization of metabolic networks as well as the development of standardized, large-scale, visually appealing maps. The implementation of SAMMI with popular constraint-based modeling toolboxes also allows for effortless visualization of simulation results of genome-scale metabolic models.
AVAILABILITY AND IMPLEMENTATION: SAMMI has been implemented as a standalone web-based tool and as plug-ins for the COBRA and COBRApy toolboxes. SAMMI and its COBRA plugins are available under the GPL 3.0 license and are available along with documentation, tutorials, and source code at www.SammiTool.com. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Mesh:

Year:  2020        PMID: 31851289     DOI: 10.1093/bioinformatics/btz927

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  2 in total

Review 1.  Constraint-Based Reconstruction and Analyses of Metabolic Models: Open-Source Python Tools and Applications to Cancer.

Authors:  Rachel H Ng; Jihoon W Lee; Priyanka Baloni; Christian Diener; James R Heath; Yapeng Su
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

2.  IDARE2-Simultaneous Visualisation of Multiomics Data in Cytoscape.

Authors:  Thomas Pfau; Mafalda Galhardo; Jake Lin; Thomas Sauter
Journal:  Metabolites       Date:  2021-05-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.